NK cell therapy refers to the clinical use of Natural Killer cells, a specialised type of white blood cell, as part of therapeutic protocols. This is a growing area of interest in clinical medicine, particularly in settings focused on immune function, longevity, and cellular health. Revital Medica now supplies NK cell therapy products alongside its established PRP kit range, making it one of the few European distributors offering both platelet-based and cellular immune therapies.
This article provides an informational overview of what NK cell therapy is, how it works, where it is used, and what is involved in the administration process.
What Are Natural Killer Cells?
Natural Killer cells, commonly abbreviated as NK cells, are a type of lymphocyte, which is a category of white blood cell. They are part of the innate immune system, meaning they provide a rapid, non-specific response to threats without requiring prior exposure to a particular pathogen or antigen.
NK cells are capable of identifying and targeting cells that display abnormal surface markers, this includes cells that have been infected by a virus, or cells that have undergone certain forms of cellular stress. When an NK cell identifies such a target, it can initiate a process that leads to the destruction of that cell.
NK cells are present naturally in the blood and various tissues of the body. Their activity and number can be influenced by factors including age, health status, and certain medical conditions. Research into how NK cell activity relates to overall immune function and health is an active area of scientific investigation.
How Is NK Cell Therapy Administered?
In clinical applications, NK cell therapy is typically delivered intravenously. The patient receives an IV infusion in a controlled clinical setting, the NK cells are introduced directly into the bloodstream, from which they can circulate to tissues throughout the body.
The administration process requires appropriate medical facilities: a clinical environment where IV infusions can be safely given, qualified nursing or medical staff to administer the infusion and monitor the patient, and the necessary protocols for handling biological materials.
The duration of the infusion, the number of sessions, and the interval between them depend on the clinical protocol being followed and the patient’s individual circumstances. Unlike PRP, which is prepared from the patient’s own blood on the day of treatment, NK cell therapy products are manufactured preparations and require specific storage and handling conditions.
What Settings Is NK Cell Therapy Used In?
NK cell therapy is used in a number of clinical contexts, including:
- Specialist wellness and longevity clinics — where immune support is part of a broader health optimisation programme
- Integrative medicine settings — where NK cell therapy may be offered alongside conventional treatments
- Post-illness recovery protocols — in some settings, NK cell infusions are used to support immune function during or following illness
- Clinical research and trial settings — NK cell therapy is an active area of investigation, and some centres offer it in the context of structured research programmes
It is important to emphasise that NK cell therapy is a specialised clinical intervention. Clinics offering this service operate within applicable national and European regulatory frameworks. Practitioners should ensure they are fully informed about the regulatory requirements in their country before introducing NK cell therapy into their practice.
How Does NK Cell Therapy Differ from PRP?
While both NK cell therapy and PRP are biological treatments used in clinical settings, they differ in several fundamental ways:
- Source — PRP is autologous, derived from the patient’s own blood at the time of treatment. NK cell therapy uses manufactured cellular preparations.
- Mechanism — PRP delivers concentrated platelets and growth factors to a specific site. NK cell therapy introduces immune cells into the systemic circulation.
- Application method — PRP is typically administered by injection or topical application. NK cell therapy is delivered intravenously.
- Regulatory classification — the regulatory requirements for NK cell therapy are generally more complex than for PRP kits.
Clinics that already offer PRP treatments may consider NK cell therapy as an expansion of their biological therapy offering, though the two services require different infrastructure, staff training, and regulatory compliance frameworks.
Revital Medica and NK Cell Products
Revital Medica offers IV NK cell treatment products to qualified clinics across Europe. As with their PRP kit range, Revital Medica serves as a distributor and provides product support, documentation, and logistical assistance to clinical partners.
Clinics exploring natural killer cell therapy as a service offering can contact Revital Medica to discuss product specifications, storage requirements, ordering, and eligibility criteria.
Further information about NK cell drip therapy products and their availability through Revital Medica is provided on the dedicated NK cell page of the Revital Medica website.
Practitioners interested in the full range of cellular immune therapy options available through Revital Medica are encouraged to visit revitalmedica.com or contact the team directly for clinical and commercial information.